SCHEMBL7040641

SCHEMBL7040641

COc1ccc(C(Cl)(C(=O)Cl)c2ccc(OC)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
ALDH1A1 P00352 4/20 0.46
MAPK1 P28482 3/20 0.46
ALOX15 P16050 2/20 0.46
LMNA P02545 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
APEX1 P27695 1/20 0.46
RECQL P46063 1/20 0.46
CA1 P00915 7/20 0.46
CA2 P00918 7/20 0.46
PLK1 P53350 1/20 0.46
HPGD P15428 2/20 0.44
CA12 O43570 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
PARP1 P09874 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1937515 0.80 MAPT (0.51) MAPTCES2CES1ALDH1A1MAPK1
SCHEMBL14473616 0.73 CA1 (0.58) MAPTALDH1A1MAPK1ALOX15LMNA
SCHEMBL10642557 0.73 CA1 (0.58) MAPTALDH1A1MAPK1ALOX15LMNA
SCHEMBL1975657 0.73 CA1 (0.58) MAPTALDH1A1MAPK1ALOX15LMNA
SCHEMBL7705952 0.73 CES1 (0.56) MAPTCES2CES1ALDH1A1CA1
SCHEMBL9590123 0.72 PPARA (0.52) MAPTCES2CES1ALDH1A1MAPK1
SCHEMBL1669219 0.72 CA1 (0.71) MAPTCES2CES1ALDH1A1MAPK1
SCHEMBL677932 0.72 CA1 (0.55) MAPTALDH1A1MAPK1ALOX15LMNA
SCHEMBL9319281 0.72 CA1 (0.55) MAPTALDH1A1MAPK1ALOX15LMNA
SCHEMBL1321231 0.72 CYP1A2 (0.70) MAPTCES1ALDH1A1ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed